Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN102408392A details a green aqueous synthesis for 2-(N,N-disubstituted amino)-4-thiazolinone. This method offers high yields, reduced costs, and scalable production for pharma intermediates.
Patent CN105130904B details a safer synthetic route for cyazofamid intermediates offering high purity and improved supply chain reliability for agrochemical manufacturing.
Novel isoxazoline preparation via Lewis acid catalysis. Mild conditions, high purity, cost-effective manufacturing for pharmaceutical intermediates.
Novel copper photocatalysis method enables mild nitrogen-alkylation. Reduces costs and improves supply chain reliability for complex pharmaceutical intermediate manufacturing.
Discover the novel chiral zinc-nitrogen complex from patent CN102887912A. Enhance asymmetric synthesis capabilities with our reliable supply of specialized catalytic intermediates.
Novel iodination method reduces cost and improves safety for liquid crystal intermediates. Reliable supply chain for high-purity pharmaceutical intermediates.
Patent CN110498750B details a mild six-step synthesis for high-purity chiral intermediates, offering significant cost reduction and scalable manufacturing for pharmaceutical applications.
Patent CN109824553B details a mild, high-yield synthesis of 2-((tert-butoxycarbonyl)amino)ethyl-1-sulfonic acid. Discover cost-effective strategies for pharma manufacturing.
Patent CN114525529B reveals a green electrochemical route for thio(seleno)phosphoric acid thioesters, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN113956157B enables room temperature synthesis. Achieve high purity trans-isomers and significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN109734686A reveals low-cost stannous chloride catalysis for high-yield benzofuran production ensuring supply chain stability and significant cost reduction.
Patent CN104478793A reveals high-selectivity synthesis route. Offers supply chain stability and cost reduction in agrochemical intermediate manufacturing.
Patent CN101538542B reveals a novel Pseudomonas esterase for high-purity mandelic acid. This biocatalytic route offers significant cost reduction and supply chain reliability for chiral intermediates.
Patent CN1751017A introduces a transimidation route for substituted phthalic anhydrides, offering significant cost reduction in polymer additive manufacturing and high-purity intermediates.
Advanced recrystallization technology for BIT intermediates reduces waste and ensures granular morphology for safer handling in biocide manufacturing.
Patent CN109705065B details a cyanide-free asymmetric synthesis of D-(-)-pantolactone using chiral phase transfer catalysis, offering high purity and scalable manufacturing for Vitamin B5 production.
Patent CN115093378B reveals high-purity 2-thiazolidinone production with enhanced safety and yield for pharmaceutical and agrochemical supply chains globally.
Patent CN102863335A reveals a green one-step synthesis for succinic acid diesters using CO2. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113582937B details a green isoxazole synthesis using TPGS-750-M. Achieves high purity without heavy metals, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111807986B details a novel copper-catalyzed C-N coupling using oxalohydrazide ligands. Discover cost-effective synthesis routes for aryl hydrazines suitable for industrial scale-up.